You are here

Merck KGaA

Merck KGaA selling manufacturing site, allergy drugs to Dermapharm

Fierce Pharma

Thu, 02/20/20 - 10:34 am

drug manufacturing

Allergan, Merck KGaA and Sai Life Sciences Invest in New Global Manufacturing Facilities

BioSpace

Thu, 01/30/20 - 10:48 am

Sai Life Sciences

drug manufacturing

Merck KGaA spinout iOnctura raises cash for cancer trials

Fierce Biotech

Thu, 01/23/20 - 11:59 am

clinical trials

Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores

Endpoints

Mon, 01/6/20 - 10:16 am

Corporate and regulatory developments over the Christmas period

EP Vantage

Thu, 01/2/20 - 11:39 pm

Ono Pharmaceutical

Xyphos Biosciences

Novartis, Merck KGaA and Biogen: Which new MS drug do doctors like best? You might be surprised

Fierce Pharma

Tue, 11/19/19 - 02:41 pm

multiple sclerosis

Merck KGaA posts higher profit and revenue as it lifts sales forecast

Marketwatch

Thu, 11/14/19 - 10:13 am

Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial

Marketwatch

Fri, 11/8/19 - 10:45 am

clinical trials

Merck KGaA wants to get in early on Chinese innovation — so it's setting up a seed fund there

Endpoints

Sat, 10/19/19 - 01:45 pm

Merck and the machine: German pharma tests real-time platform to forestall drug shortages

Fierce Pharma

Tue, 10/15/19 - 10:13 pm

machine learnings

artificial intelligence

Merck seeks partner for disease-modifying osteoarthritis drug

PM Live

Wed, 10/9/19 - 11:08 pm

Merck KGaA nabs FDA “Breakthrough” tag for MET-targeting lung cancer drug

Pharmaforum

Wed, 09/11/19 - 11:48 pm

non-small cell lung cancer

Shifting focus to oncology, GSK recruits a cancer vet as new chief of US pharmaceuticals — adding another woman to the top ranks of biopharma

Endpoints

Mon, 08/12/19 - 10:49 am

Maya Martinez-Davis

Tackling the remaining challenges of multiple sclerosis

Pharmaforum

Sat, 08/10/19 - 01:52 pm

multiple sclerosis

Startup offering free DNA sequencing signs first pharma sponsor

Stat

Tue, 06/11/19 - 09:37 am

Nebula Genomics

Merck and Pfizer’s Bavencio approved for renal cell carcinoma

Pharmaforum

Wed, 05/15/19 - 10:35 am

advanced renal cell carcinoma

Merck KGaA retools F-star pact, walks away from lead PD-L1 drug

Fierce Biotech

Tue, 05/14/19 - 11:36 pm

bispecific antibodies

German Merck finally gets yes for MS drug Mavenclad

Biopharma Dive

Tue, 04/2/19 - 04:20 pm

multiple sclerosis

Still hunting a blockbuster, Merck KGaA scores a win in the FDA approval column — more than 13 years in the making

Endpoints

Sun, 03/31/19 - 03:53 pm

multiple sclerosis

Merck KGaA injecting €150M into biologics site where it makes immunotherapies

Fierce Pharma

Thu, 03/28/19 - 08:00 pm

drug manufacturing

Pages